Fræðigrein

- a report of two cases and a review of the literature

The incidence of encapsulating peritoneal sclerosis in patients on peritoneal dialysis seems to be increasing worldwide. In Iceland, two cases of encapsulating peritoneal sclerosis have recently been diagnosed (cumulative incidence 1.6%). The patients followed a similar course; the disease was diagnosed in the wake of a bacterial peritonitis, steroid treatment was effective during the acute phase but eventually surgical treatment was needed and a successful enterolysis performed.

Table I. Information about the peritoneal dialysis fluids used at the Department of Nephrology, Landspitali, University Hospital.

Dialysis fluid	Main content	Osmolarity	pH
Dianeal®*	Glucose 75, 125 or 215 mmol/L	340, 390 or 480 mosm/kg	5.5
Physioneal®	Glucose 75, 125 or  215 mmol/L	340, 390 or 480 mosm/kg	7.4
Extraneal®	Icodextrin 7.5%**	284 mosm/kg	5.5
Nutrineal®	Amino acids 1.1%	365 mosm/kg	6.7

*Rarely used by now

**A glucose polymer that produces colloid osmotic pressure

 

Table II. The table shows the results of large epidemiological studies on encapsulating sclerosing peritonitis (EPS) in patients treated with peritoneal dialysis (PD) (11-14).